Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunomodulatory Drugs”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Testing effectiveness (Phase 2)UnknownNCT01006681
What this trial is testing

Vaccination Against Influenza H1N1 in Rheumatic Diseases

Who this might be right for
InfluenzaRheumatic Diseases
Tel-Aviv Sourasky Medical Center 400
Testing effectiveness (Phase 2)WithdrawnNCT01647165
What this trial is testing

Phase II Study of Subcutaneous (SC) Bortezomib, Lenalidomide and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma; Followed by SC Bortezomib Maintenance

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI)
Not applicableUnknownNCT04769258
What this trial is testing

Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD)

Who this might be right for
Inflammatory Bowel Diseases
Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) 1,380
Testing effectiveness (Phase 2)Active Not RecruitingNCT04764942
What this trial is testing

Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Mayo Clinic 39
Testing effectiveness (Phase 2)Study completedNCT01360970
What this trial is testing

Hepatitis A Vaccine in Patients With Immunomodulating Drugs

Who this might be right for
Response to Hepatitis A Vaccine
Lars Rombo 68
Testing effectiveness (Phase 2)Study completedNCT03525678
What this trial is testing

Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 221
Large-scale testing (Phase 3)Active Not RecruitingNCT04096066
What this trial is testing

A Trial That Compare Two Treatments in Newly Diagnosed Myeloma Patients Not Eligible for Transplant

Who this might be right for
Multiple MyelomaNew Diagnosis Tumor
Fondazione EMN Italy Onlus 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT04649359
What this trial is testing

MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb

Who this might be right for
Multiple Myeloma
Pfizer 187
Testing effectiveness (Phase 2)Ended earlyNCT01545518
What this trial is testing

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

Who this might be right for
Epilepsy, CryptogenicEpilepsy, PartialSeizure Disorder+2 more
Emory University 20
Not applicableStudy completedNCT06264206
What this trial is testing

Effect of Immunomodulatory Treatment on IVF (in Vitro Fertilization) Outcomes in Patients With KIR AA Genotype

Who this might be right for
Immunomodulatory DrugsKiller-cell Immunoglobulin-like Receptors (KIRs)KIR Alleles (KIR AA)
Calla IVF Center 65
Testing effectiveness (Phase 2)Ended earlyNCT00751296
What this trial is testing

Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukaemia
University Health Network, Toronto 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT04933539
What this trial is testing

Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)UnknownNCT05941845
What this trial is testing

Interferon Alfa Therapy Based on Th17 Profile in Membranous Nephropathy

Who this might be right for
Membranous Nephropathy
Centre Hospitalier Universitaire de Nice 5
Large-scale testing (Phase 3)WithdrawnNCT05461209
What this trial is testing

Comparing Talquetamab to Belantamab Mafodotin in Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/ Refractory Multiple Myeloma
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Active Not RecruitingNCT04124497
What this trial is testing

A Trial for Relapsed and Relapsed/Refractory Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaDeletion 17P Syndrome
Fondazione EMN Italy Onlus 45
Not applicableUnknownNCT02469207
What this trial is testing

Regenerative Cellular Therapies, Physiology, Pathology and Developmental Biology

Who this might be right for
Graft RejectionTransplantationDiabetes Mellitus
Cambridge University Hospitals NHS Foundation Trust 50
Testing effectiveness (Phase 2)Ended earlyNCT05288062
What this trial is testing

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma+1 more
Mayo Clinic 17
Testing effectiveness (Phase 2)Study completedNCT04257448
What this trial is testing

Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer

Who this might be right for
Pancreas CancerPancreatic AdenocarcinomaPancreatic Ductal Adenocarcinoma
GWT-TUD GmbH 75
Testing effectiveness (Phase 2)UnknownNCT01446978
What this trial is testing

Three Doses of Hepatitis A Vaccine in Patients With Immunomodulating Drugs

Who this might be right for
Vaccine Response Impaired
Sormland County Council, Sweden 150
Not applicableStudy completedNCT01879046
What this trial is testing

Regenerative Medicine of Articular Cartilage: Characterization and Comparison of Chondrogenic Potential and Immunomodulatory Adult Mesenchymal Stem Cells

Who this might be right for
Knee Osteoarthritis
Nantes University Hospital 35
Load More Results